Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.551, 2008-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Botox injects meaningful improvements into QOL
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 640, 2011-01 ,pp. :
HAART introduction in Italy provides cost, QOL advantage
Inpharma, Vol. 1, Iss. 1422, 2004-01 ,pp. :
Somatropin provides long-term QOL improvement in GHD
Inpharma, Vol. 1, Iss. 1441, 2004-01 ,pp. :
FOLFIRINOX provides QOL benefits in pancreatic cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 669, 2013-01 ,pp. :
HAART introduction in Italy provides cost, QOL advantage
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 445, 2004-01 ,pp. :